Evidence map›Paper›PMID 11375419›Full record

ArticleThe Journal of clinical investigation2001

Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis.

A Nakajima, C M Seroogy, M R Sandora, I H Tarner, G L Costa, C Taylor-Edwards, M H Bachmann, C H Contag, C G Fathman

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
21.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 180 citations in OpenAlex.

  1. Review
  2. Non-radioactive imaging strategies forPhysical sciences reviews · 2023
    Article
  3. Article
  4. Review
  5. Virus-based nanoparticles as platform technologies for modern vaccines.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2016
    Review
  6. Article
  7. Article
  8. IL-12p40 Homodimer Ameliorates Experimental Autoimmune Arthritis.Journal of immunology (Baltimore, Md. : 1950) · 2015
    Article
  9. Review
  10. Article
  11. In vivo Noninvasive Small Animal Molecular Imaging.Osong public health and research perspectives · 2012
    Review
  12. Immunosuppressive exosomes: a new approach for treating arthritis.International journal of rheumatology · 2012
    Article
  13. Review
  14. Optical imaging: new tools for arthritis.Integrative biology : quantitative biosciences from nano to macro · 2010
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

A NakajimaDepartment of Medicine, Division of Immunology and Rheumatology, Stanford University, School of Medicine, Stanford, California 94305-5111, USA.
C M Seroogy
M R Sandora
I H Tarner
G L Costa
C Taylor-Edwards
M H Bachmann
C H Contag
C G Fathman
Stanford University · USCenter for Rheumatology · US

Funding

THE ROLE OF TNF-ALPHA IN LYMPHOCYTE DEVELOPMENT IN NOD MICEP01AI036535 · NIAID · STANFORD UNIVERSITY · PI FATHMAN, CHARLES GARRISON · 1994 to 2008
$6.6M
RETROVIRAL MEDIATED GENE THERAPY OF RHEUMATOID ARTHRITISN01AR062227 · NIAMS · STANFORD UNIVERSITY · PI FATHMAN, CHARLES GARRISON · 1996 to 2000
$528k
USE OF ALTERED PEPTIDE LIGANDS IN THE TREATMENT OF DIABETESP01AI039646 · NIAID · STANFORD UNIVERSITY · PI FATHMAN, CHARLES GARRISON · 1996 to 1999
–
NIAID NIH HHS AI-36535NIAID NIH HHS AI-39646NIAID NIH HHS P01 AI036535NIAMS NIH HHS N01-AR-6-2227
6 · The paper itself

Abstract

Autoantigen-specific T cells have tissue-specific homing properties, suggesting that these cells may be ideal vehicles for the local delivery of immunoregulatory molecules. We tested this hypothesis by using type II collagen-specific (CII-specific) CD4(+) T hybridomas or primary CD4(+) T cells after gene transfer, as vehicles to deliver an immunoregulatory protein for the treatment of collagen-induced arthritis (CIA), a mouse model of rheumatoid arthritis (RA). CII-specific T cells or hybridomas were transduced using retroviral vectors to constitutively express the IL-12 antagonist, IL-12 p40. Transfer of engineered CD4(+) T cells after immunization significantly inhibited the development of CIA, while cells transduced with vector control had no effect. The beneficial effect on CIA of IL-12 p40-transduced T cells required TCR specificity against CII, since transfer of T cells specific for another antigen producing equivalent amounts of IL-12 p40 had no effect. In vivo cell detection using bioluminescent labels and RT-PCR showed that transferred CII-reactive T-cell hybridomas accumulated in inflamed joints in mice with CIA. These results indicate that the local delivery of IL-12 p40 by T cells inhibited CIA by suppressing autoimmune responses at the site of inflammation. Modifying antigen-specific T cells by retroviral transduction for local expression of immunoregulatory proteins thus offers a promising strategy for treating RA.

Indexed as

Adoptive TransferAnimalsArthritis, RheumatoidCollagenGenetic TherapyHybridomasInterleukin-12MaleMiceMice, Inbred DBARetroviridaeT-Lymphocyte SubsetsCollagenInterleukin-12

Identifiers

PMID11375419
PMCPMC209299
OpenAlexW1971050137

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.